🇺🇸 FDA
Pipeline program

Placebo tablets without active pharmaceutical ingredient closely resembling the imp, Hetrombopag Olamine

SHR8735-303

Phase 3 small_molecule active

Quick answer

Placebo tablets without active pharmaceutical ingredient closely resembling the imp, Hetrombopag Olamine for Chemotherapy induced thrombocytopenia is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Chemotherapy induced thrombocytopenia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials